?? ACC 2024 ??? Large prospective RCT demonstrates IVUS-guided DCB intervention in fempop ?? disease provides significantly improved clinical outcomes! Now if only there was a next generation IVUS platform with better image quality, improved ease of use, and AI-enabled capabilities that clinicians actually wanted to use… Check out —> Evident Vascular, Inc. Cc: Howard Rosen
Director of Vascular Intervention, BIDMC; Section Head, Interventional Cardiology and Vascular Research, Smith Center for Outcomes Research; Associate Professor of Medicine, Harvard Medical School
Second Prospective Randomized Control Trial Demonstrating the Benefit of Peripheral IVUS! 237 patients with fempop disease randomized to IVUS-guided DCB treatment vs angio-guided DCB treatment. 14% improvement in patency at 1 year. Summary of results here: https://lnkd.in/gU-3Vggz This aligns with the 17% patency improvement seen in the Allan et al 150 person fem-pop RCT trail published in 2022: (https://lnkd.in/gRtz-rQr). Time is now to change your peripheral practice!! Learn more about peripheral IVUS here: https://lnkd.in/g-m7EpWg Society for Vascular Medicine Society for Cardiovascular Angiography & Interventions Society of Interventional Radiology VIVA Physicians